Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    Abbott Laboratories (ABT) Insider Trading Activity

    Healthcare • Medical Devices • 114,000 employees

    Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

    Total Value

    -$66,894,912.22

    Total Shares

    -3,110

    Average Trade Value

    -$3,344,745.61

    Most Active Insider

    Ford Robert B

    Total Activity: $71,573,292

    Largest Single Transaction

    $37,435,200

    by Ford Robert B on Feb 5, 2025

    30-Day Activity

    9 Transactions

    Volume: 2,644 shares
    Value: $46,009,332

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Chairman and CEO
    Feb 5, 2025 285,388 $37,435,200 220,059 (-129.7%) Sale
    Chairman and CEO
    Feb 5, 2025 285,388 $10,958,899 505,447 (+56.5%) Exercise/Conversion
    Executive Vice President
    Jan 30, 2025 58,428 $2,243,635 243,234 (+24.0%) Exercise/Conversion
    Executive Vice President
    Jan 30, 2025 58,428 $7,482,629 184,806 (-31.6%) Sale
    Executive Vice President
    Jan 30, 2025 23,771 $3,054,574 125,697 (-18.9%) Sale
    Executive Vice President
    Jan 30, 2025 23,771 $912,806 149,468 (+15.9%) Exercise/Conversion
    Executive Vice President
    Jan 29, 2025 131,360 $16,859,675 184,806 (-71.1%) Sale
    Executive Vice President
    Jan 29, 2025 131,360 $5,044,224 316,166 (+41.5%) Exercise/Conversion
    Executive Vice President
    Jan 28, 2025 2,644 $336,819 0 Sale
    Executive Vice President
    Oct 21, 2024 157,421 $7,398,787 342,227 (+46.0%) Exercise/Conversion
    Executive Vice President
    Oct 21, 2024 1,249 $148,394 340,978 (-0.4%) Sale
    Executive Vice President
    Oct 21, 2024 5,901 $697,203 335,077 (-1.8%) Sale
    Executive Vice President
    Oct 21, 2024 150,271 $17,578,702 184,806 (-81.3%) Sale
    Chairman and CEO
    Sep 12, 2024 127,436 $5,989,492 347,495 (+36.7%) Exercise/Conversion
    Chairman and CEO
    Sep 12, 2024 80,299 $9,317,896 281,439 (-28.5%) Sale
    Chairman and CEO
    Sep 12, 2024 61,380 $7,175,322 220,059 (-27.9%) Sale
    Chairman and CEO
    Sep 12, 2024 14,243 $696,483 361,738 (+3.9%) Exercise/Conversion
    Vice President
    Sep 4, 2024 27 $3,100 18,681 (-0.1%) Sale
    Executive Vice President
    Sep 1, 2024 387 $43,835 38,966 (-1.0%) Payment of Exercise Price
    Vice President
    Sep 1, 2024 52 $5,890 18,708 (-0.3%) Payment of Exercise Price